Ebid et al., (2012) have performed a study to evaluate the prevalence of P53, P21Ser31Arg and MDM2-309T>G polymorphism s in AML and to compare it to apparently normal healthy controls for assessment of impact on risk in an Egyptian population. This evidence concerns the gene MDM2 and acute myeloid leukemia.